Skip to Content

Myasthenia Gravis: New Modes of Action and New Targets Are Becoming Available

The treatment of myasthenia gravis has followed an escalation principle, however the dilemma is that severe symptoms usually occur within the first two years of diagnosis. In this MEDtalk, Sini Laakso takes you through the current and coming treatment options, where new modes of action and new targets are becoming available for patients.

Sini Laakso

Få tillgång

Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.

Back to top